Incidence and correlates of hepatitis C virus infection in a large cohort of prisoners who have injected drugs

作者: Kathryn J Snow , Jesse T Young , David B Preen , Nicholas G Lennox , Stuart A Kinner

DOI: 10.1186/1471-2458-14-830

关键词:

摘要: Background: Hepatitis C virus (HCV) infection is common among prisoners, particularly those with a history of injecting drug use (IDU). Incarcerated people who inject drugs frequently report high-risk practices both in prison and the community. In spite rising morbidity mortality, utilisation HCV-related services Australia has been persistently low. This study aimed to describe incidence, prevalence correlates HCV seropositivity large cohort prisoners have injected drugs, identify receiving confirmation active infection. Methods: Data-linkage State-wide statutory notifiable diseases surveillance system was used investigate incidence notified seropositivity, seroconversion confirmed 735 IDU, over 14 years follow up. test results from medical records were testing positive prison. Results: The crude notification 5.1 cases per 100 person-years. By end up, 55.1% had subject notification, 47.4% tested seropositive. multivariable analyses, strongly associated as opioid compared injection other drugs. rate reported diagnostic infections very low, at 6.6 confirmations seropositive participants year. Conclusions: Injecting highlighting need for increased provision mitigate risk transmission within prisons. Once identified through screening, IDU incarceration may not be promptly services, which are necessary if they access treatment. Improving will particular importance coming years, mortality increasing, next generation therapies becoming more widely available.

参考文章(32)
David Lim, Tony Butler, D. Callander, National Prison Entrants’ Bloodborne Virus & Risk Behaviour Survey 2004, 2007, And 2010 Kirby Institute. pp. 1- 228 ,(2011)
H.‐H. Thein, S. R. Walter, H. F. Gidding, J. Amin, M. G. Law, J. George, G. J. Dore, Trends in incidence of hepatocellular carcinoma after diagnosis of hepatitis B or C infection: a population-based cohort study, 1992-2007. Journal of Viral Hepatitis. ,vol. 18, ,(2011) , 10.1111/J.1365-2893.2011.01440.X
Avril Taylor, Alison Munro, Elizabeth Allen, Karen Dunleavy, Sheila Cameron, Laura Miller, Matthew Hickman, Low incidence of hepatitis C virus among prisoners in Scotland. Addiction. ,vol. 108, pp. 1296- 1304 ,(2013) , 10.1111/ADD.12107
M. Guirgis, K. Yan, Y. M. Bu, A. Zekry, General practitioners' knowledge and management of viral hepatitis in the migrant population. Internal Medicine Journal. ,vol. 42, pp. 497- 504 ,(2012) , 10.1111/J.1445-5994.2011.02440.X
Stuart A. Kinner, Rebecca Jenkinson, Maelenn Gouillou, M.-J. Milloy, High-risk drug-use practices among a large sample of Australian prisoners Drug and Alcohol Dependence. ,vol. 126, pp. 156- 160 ,(2012) , 10.1016/J.DRUGALCDEP.2012.05.008
Andrés Marco, Carlos Gallego, Joan A. Caylà, Incidence of Hepatitis C Infection among Prisoners by Routine Laboratory Values during a 20-Year Period PLoS ONE. ,vol. 9, pp. e90560- ,(2014) , 10.1371/JOURNAL.PONE.0090560
Kate A. Dolan, James Shearer, Bethany White, Jialun Zhou, John Kaldor, Alex D. Wodak, Four-year follow-up of imprisoned male heroin users and methadone treatment: mortality, re-incarceration and hepatitis C infection. Addiction. ,vol. 100, pp. 820- 828 ,(2005) , 10.1111/J.1360-0443.2005.01050.X
Lorraine Yap, Susan Carruthers, Sandra Thompson, Wendy Cheng, Jocelyn Jones, Paul Simpson, Alun Richards, Hla-Hla Thein, Paul Haber, Andrew Lloyd, Tony Butler, None, A Descriptive Model of Patient Readiness, Motivators, and Hepatitis C Treatment Uptake among Australian Prisoners PLOS ONE. ,vol. 9, pp. 1- 11 ,(2014) , 10.1371/JOURNAL.PONE.0087564